It is called a targeted therapy as it precisely targets the CD38 which happen to be overexpressed on the multiple myeloma cells. Daratumumab is from a class of medicines identified as CD38 monoclonal antibodies. Darzalex mechanism of action is by binding to the CD38 protein on the area with the https://adhdozempic.com/